57. Utility of Blind Pap Smears

Pap smear (PS) screening is recommended to women beginning at 21 years of age, and earlier in immunocompromised (IC) patients; a traditional PS reports specimen adequacy, presence of endocervical component (ECC) and cytology. Most patients are able to undergo PS in the office setting, however, certain populations may require the operating room (OR) setting, which is both more costly and carries greater risks than PS in the outpatient setting. Because recent studies have shown promise with less invasive PS screening, we aimed to assess the utility of a blind pap (BP) compared to traditional pap (TP), hypothesizing that there would be no difference between the two methods.
Source: Journal of Pediatric and Adolescent Gynecology - Category: OBGYN Authors: Source Type: research